USD 15.6
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.79 Billion EUR | 49.35% |
2022 | 1.2 Billion EUR | 13.58% |
2021 | 1.06 Billion EUR | 9.53% |
2020 | 968.06 Million EUR | 38.1% |
2019 | 701.01 Million EUR | 29.89% |
2018 | 539.71 Million EUR | 90.04% |
2017 | 283.99 Million EUR | 60.09% |
2016 | 177.39 Million EUR | 41.26% |
2015 | 125.57 Million EUR | 48.31% |
2014 | 84.67 Million EUR | 53.13% |
2013 | 55.29 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 560.67 Million EUR | 0.08% |
2024 Q1 | 560.21 Million EUR | 5.44% |
2023 Q4 | 531.31 Million EUR | 11.74% |
2023 FY | 1.79 Billion EUR | 49.35% |
2023 Q3 | 475.5 Million EUR | 13.24% |
2023 Q1 | 372.05 Million EUR | 13.49% |
2023 Q2 | 419.88 Million EUR | 12.86% |
2022 Q1 | 304.78 Million EUR | 5.82% |
2022 FY | 1.2 Billion EUR | 13.58% |
2022 Q4 | 327.83 Million EUR | 15.22% |
2022 Q3 | 284.51 Million EUR | -0.94% |
2022 Q2 | 287.22 Million EUR | -5.76% |
2021 Q2 | 250.38 Million EUR | -11.85% |
2021 Q4 | 288.02 Million EUR | 21.09% |
2021 Q1 | 284.05 Million EUR | 7.3% |
2021 FY | 1.06 Billion EUR | 9.53% |
2021 Q3 | 237.85 Million EUR | -5.01% |
2020 Q4 | 264.71 Million EUR | 10.91% |
2020 Q2 | 232.67 Million EUR | 0.3% |
2020 Q3 | 238.68 Million EUR | 2.58% |
2020 Q1 | 231.98 Million EUR | 20.92% |
2020 FY | 968.06 Million EUR | 38.1% |
2019 Q2 | 163.63 Million EUR | -6.31% |
2019 FY | 701.01 Million EUR | 29.89% |
2019 Q3 | 170.87 Million EUR | 4.43% |
2019 Q4 | 191.85 Million EUR | 12.28% |
2019 Q1 | 174.64 Million EUR | 15.48% |
2018 Q2 | 126.56 Million EUR | -3.14% |
2018 Q1 | 130.66 Million EUR | 40.76% |
2018 Q3 | 131.25 Million EUR | 3.7% |
2018 Q4 | 151.23 Million EUR | 15.22% |
2018 FY | 539.71 Million EUR | 90.04% |
2017 Q1 | 63.77 Million EUR | 21.01% |
2017 FY | 283.99 Million EUR | 60.09% |
2017 Q2 | 62.92 Million EUR | -1.33% |
2017 Q3 | 64.45 Million EUR | 2.43% |
2017 Q4 | 92.82 Million EUR | 44.01% |
2016 Q1 | 41.01 Million EUR | 18.75% |
2016 Q4 | 52.7 Million EUR | 23.93% |
2016 Q3 | 42.52 Million EUR | 3.34% |
2016 Q2 | 41.15 Million EUR | 0.34% |
2016 FY | 177.39 Million EUR | 41.26% |
2015 Q1 | 30.26 Million EUR | 0.0% |
2015 FY | 125.57 Million EUR | 48.31% |
2015 Q3 | 30.51 Million EUR | 0.82% |
2015 Q4 | 34.53 Million EUR | 13.18% |
2015 Q2 | 30.26 Million EUR | 0.0% |
2014 FY | 84.67 Million EUR | 53.13% |
2013 FY | 55.29 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Alternative Energy Partners, Inc. | - USD | -Infinity% |
Allstar Health Brands, Inc. | - USD | -Infinity% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | -821.312% |
Café Serendipity Holdings, Inc. | 44.55 Thousand USD | -4037063.057% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | - USD | -Infinity% |
HealthWarehouse.com, Inc. | 20.28 Million USD | -8768.157% |
LIGAND PHARMACEUTICAL INC | 131.31 Million USD | -1269.814% |
MedGen, Inc. | 1.05 USD | -171310285614.286% |
Omni Health, Inc. | 4.69 Million USD | -38209.822% |
Oxford Investments Holdings Inc. | 61.16 Thousand USD | -2940632.748% |
Pineapple, Inc. | 381.89 Thousand USD | -470914.69% |
ScripsAmerica, Inc. | 30.85 Million USD | -5729.778% |